Thomas K. Baker
Eli Lilly (United States)(US)South Western Sydney Local Health District(AU)
Publications by Year
Research Areas
Estrogen and related hormone effects, Computational Drug Discovery Methods, Toxic Organic Pollutants Impact, Carcinogens and Genotoxicity Assessment, Gene expression and cancer classification
Most-Cited Works
- → The future of drug safety testing: expanding the view and narrowing the focus(2009)280 cited
- → Temporal Gene Expression Analysis of Monolayer Cultured Rat Hepatocytes(2001)146 cited
- → Gene Expression Analysis of the Acute Phase Response Using a Canine Microarray(2003)65 cited
- → Oxidative stress in nongenotoxic carcinogenesis(1995)61 cited
- → Relating Molecular Properties and in Vitro Assay Results to in Vivo Drug Disposition and Toxicity Outcomes(2012)55 cited
- → Inhibition of gap junctional intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rat hepatocytes(1995)49 cited
- → Advances in blood–brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure